Biosynthetic binding proteins for immuno-targeting
CN101180074A
Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor(tfpi)
EP1910557A2
Cancer-related genes
US2006234256A1
Double stranded RNA receptor (dsRNA-R) and methods relating thereto
CN101213205A
Group B streptococcus
US2006122376A1
Protein complexes having factor VIII:C activity and production thereof
WO2006042027A2
Immunogenic and therapeutic compositions for streptococcus pyogenes
WO2006039656A2
Modified small interfering rna molecules and methods of use
BRPI0515316A
imidazoquinoline compounds
DK200501169A
NANBV diagnostics and vaccines
WO2006033713A2
Methods for ciprofloxacin inhalation
US2009317420A1
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
ZA200505460B
Antibacterial agents
WO2006002422A2
Compounds for immunopotentiation
CN1993331A
N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer
WO2005123127A2
Methods for treating cancer using prss15 as a target
CN101426937A
Fusion proteins comprising CD4 minimal modules and methods of use thereof
WO2005113507A1
Substituted quinoline derivatives as mitotic kinesin inhibitors
